Ascletis Pharma Inc. (OTCMKTS:ASCLF) Short Interest Up 100.0% in September

Ascletis Pharma Inc. (OTCMKTS:ASCLF) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 6,000 shares, a growth of 100.0% from the September 15th total of 3,000 shares. Based on an average trading volume of 1,100 shares, the short-interest ratio is currently 5.5 days. Based on an average trading volume of 1,100 shares, the short-interest ratio is currently 5.5 days.

Ascletis Pharma Price Performance

Shares of Ascletis Pharma stock opened at $1.22 on Tuesday. Ascletis Pharma has a twelve month low of $0.16 and a twelve month high of $1.98. The firm’s 50-day moving average price is $1.56 and its 200 day moving average price is $1.18.

About Ascletis Pharma

Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.